Early Drug Development Group (E2DG) Revenue
Pharmaceutical Manufacturing • 
Boulogne-Billancourt, Île-de-France, France • 1-10 Employees
Early Drug Development Group (E2DG) revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Early Drug Development Group (E2DG)
Christophe Mazars
CEO
Company overview
| Headquarters | 1 Place Paul Verlaine, Boulogne Billancourt, 92100, FR |
| Phone number | +3315242358 |
| Websites | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Partnerships, Innovation, Oncology, Drug Development |
| Founded | 2015 |
| Employees | 1-10 |
| Socials |
Early Drug Development Group (E2DG) Email Formats
Early Drug Development Group (E2DG) uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@e2dg.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@e2dg.com | 100% |
About Early Drug Development Group (E2DG)
We offer professional support all along the drug development life cycle, from lead optimization to Phase I clinical trials in oncology. We optimize and accelerate your R&D programs, based on our drug positioning-oriented philosophy. Early Drug Development Group is focused on building partnerships and strategic alliances with academic research institutions, universities, governmental agencies, small size biotechnology partners and investment funds. COLLABORATION WITH US IMPROVES YOUR RESOURCES INVESTMENT AND STRENGTHENS YOUR EARLY DRUG DEVELOPMENT PROGRAM IN ONCOLOGY. YOUR KEY BENEFITS • Assistance on preclinical, pharmacological and CMC approaches, clinical studies design, regulatory strategies and trials implementation to optimize and accelerate oncology R&D programs through our strong medical input and oncology-experienced staff. • Optimization, management and execution of an efficient, customized and cost-effective development program of novel drugs through access to a highly skilled and coordinated team of world-class R&D experts. • Broad capabilities in preclinical, pharmacokinetic and radio-pharmacology studies to guide clinical development. • Guidance on FDA/EMA regulation and IND submission. • Clinical Phase I study design and trial implementation. • Due diligences on chemistry, molecular pharmacology, ADME/PK and CMC areas. Independent medical review of clinical studies data. • Benefit from our strategic and hands-on involvement in projects which synergizes the best industry expertise with excellent cost-effective outsourced solutions to solve complex drug development challenges. • Management for the transfer of projects from academic to company environment. Evaluation of the financial costs of pursuing a full drug development program.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Early Drug Development Group (E2DG) has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Early Drug Development Group (E2DG) has never raised funding before.
Early Drug Development Group (E2DG) Tech Stack
Discover the technologies and tools that power Early Drug Development Group (E2DG)'s digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Form builders
Programming languages
Miscellaneous
SEO
Font scripts
Blogs
JavaScript libraries
Video players
Databases
Miscellaneous
Israel
United States
Frequently asked questions
4.8
40,000 users
